Atlas Trials

Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Clinical trial NCT00002582 · COMPLETED

Trial details

NCT number
NCT00002582
Sponsor
Institute of Cancer Research, United Kingdom
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
1993-06-01
Enrollment
6000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.